Corporate News     25-Sep-19
Astrazeneca Pharma receives DCGI approval for launch of diabetes drug in India
Astrazeneca Pharma India has received Import and Market permission in Form 45 (Marketing Authorization) from the Drugs Controller General of India for FDC of Dapagliflozin 10mg + Saxagliptin 5mg film coated tablets.

The receipt of this Import and Market permission paves way for the launch of FDC of Dapagliflozin 10mg + Saxagliptin 5mg film coated tablets (QTERN®) in India, subject to the receipt of other related statutory approvals and licenses.

FDC of Dapagliflozin 10mg + Saxagliptin 5mg is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus (T2DM).

Previous News
  Astrazeneca Pharma India standalone net profit declines 46.08% in the December 2023 quarter
 ( Results - Announcements 09-Feb-24   07:42 )
  AstraZeneca Pharma Q4 PAT soars 129% YoY to Rs 39 cr
 ( Hot Pursuit - 28-May-24   11:45 )
  Astrazeneca Pharma India standalone net profit rises 172.47% in the September 2022 quarter
 ( Results - Announcements 11-Nov-22   17:08 )
  Astrazeneca Pharma India standalone net profit rises 167.30% in the June 2023 quarter
 ( Results - Announcements 14-Aug-23   14:37 )
  AstraZeneca Pharma India and Mankind Pharma ink distribution agreement
 ( Corporate News - 11-Mar-24   15:39 )
  Astrazeneca Pharma India standalone net profit rises 236.78% in the June 2019 quarter
 ( Results - Announcements 07-Aug-19   16:27 )
  Astrazeneca Pharma rises on planning to launch Enhertu
 ( Hot Pursuit - 21-Dec-23   10:01 )
  Astrazeneca Pharma gets nod from CDSCO to import Olaparib film coated tablets
 ( Hot Pursuit - 22-Nov-23   11:07 )
  Astrazeneca Pharma India to announce Quarterly Result
 ( Corporate News - 01-Nov-22   10:34 )
  Astrazeneca Pharma India schedules AGM
 ( Corporate News - 18-Jul-20   17:12 )
  Astrazeneca Pharma India to announce Quarterly Result
 ( Corporate News - 24-Oct-20   10:03 )
Other Stories
  Tinna Trade raises Rs 49 cr to fund its growth plans
  06-Jul-24   11:10
  Integra Essentia announces merger with G G Engineering
  06-Jul-24   11:05
  Ugro Capital to raise Rs 75 cr via NCD issuance
  06-Jul-24   10:58
  Board of D.P. Abhushan approves preferential allotment of shares and warrants
  06-Jul-24   10:50
  Life Insurance Corporation of India invest Rs 14 cr in Sri Lankan subsidiary
  06-Jul-24   10:49
  High Energy Batteries (India) to discuss results
  06-Jul-24   10:29
  Havells India schedules board meeting
  06-Jul-24   10:29
  Axis Bank announces board meeting date
  06-Jul-24   10:29
  Mastek to conduct board meeting
  06-Jul-24   10:29
  Oriental Hotels to conduct board meeting
  06-Jul-24   10:29
Back Top